Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 3:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (66.7%)Not Applicable
1 (33.3%)The Effects of High Energy Acoustic Shock Wave Therapy on Local Skin Perfusion and DFUs
Not Applicable
Terminated
- Conditions
- Diabetic Foot Ulcer
- First Posted Date
- 2018-08-21
- Last Posted Date
- 2021-11-08
- Lead Sponsor
- SANUWAVE, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT03640988
- Locations
- 🇺🇸
University Hospital, Newark, New Jersey, United States
A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers
Phase 3
- Conditions
- Diabetic Foot Ulcers
- First Posted Date
- 2013-04-04
- Last Posted Date
- 2014-03-06
- Lead Sponsor
- SANUWAVE, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT01824407
- Locations
- 🇺🇸
Associated Foot and Ankle Specialists, Phoenix, Arizona, United States
🇺🇸Southern Arizona VA Healthcare System, Tucson, Arizona, United States
🇺🇸Long Beach VA Healthcare System, Long Beach, California, United States
Effectiveness of dermaPACE™ Device and Standard Treatment Compared to Standard Treatment Alone for Diabetic Foot Ulcers
Phase 3
Completed
- Conditions
- Diabetic Foot Ulcers
- First Posted Date
- 2007-09-28
- Last Posted Date
- 2014-04-14
- Lead Sponsor
- SANUWAVE, Inc.
- Target Recruit Count
- 206
- Registration Number
- NCT00536744
- Locations
- 🇺🇸
Phoenix VA Health Care System, Phoenix, Arizona, United States
🇺🇸HOPE Research Insititute, Phoenix, Arizona, United States
🇺🇸Southern Arizona VA Healthcare System (SAVAHCS), Tucson, Arizona, United States
News
No news found